Cardio-Protective Drugs Market: Global Market Size and Forecast 2018-2023

Posted by pranshu@95 on August 12th, 2019

According to OMR analysis, the Global Cardio-Protective Drugs Market is estimated to grow at a significant CAGR during the forecast period (2018-2023). Factors motivating the growth of this market include increasing geriatric population and increase in excessive alcohol consumption & smoking. Other factors that are driving the growth of the market include increasing prevalence of chronic heart diseases and technological advancement in healthcare industry. High cost of medication and diagnostics procedure of heart disease are the major restraining factors restraining to the growth of this market

A full report of global cardio-protective drugs market is available at: https://www.omrglobal.com/industry-reports/cardioprotective-drug-market/

Furthermore, the global cardio-protective drugs are segmented on the basis of application, type, distribution channels, treatment, and regional outlook. The report provides detailed & insightful chapters which include market overview, key findings, strategic recommendations, market estimations, market determinants, key company analysis, market insights, company profiling, market segmentation, geographical analysis, analyst insights and predictive analysis of the market.

Market Segmentation

1. Global Cardio-Protective Drugs Market By Treatment

• Cholesterol Lowering
• Revascularization
• Anti-Inflammatory
• Blood Thinners & Clot Busters

2. Global Cardio-Protective Drugs Market By Type

• Antiplatelets
• Ace Inhibitors & Arbs
• Beta-Blockers
• Polypills
• Statins & Others

3. Global Cardio-Protective Drugs Market By Application

• Arrhythmia
• Coronary Artery Disease
• Ischemic Heart Disease
• Cardiovascular Disease
• Hyperlipidaemia
• Peripheral Heart Disease
• Hypertension

4. Global Cardio-Protective Drugs Market By Distribution Channel

• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy6

Region Covered

• North America (US and Canada)
• Europe (United Kingdom, Germany, France, Spain, and Italy)
• Asia-Pacific (China, India, South Korea, and Japan)
• Rest of the World (Middle East & Africa and Latin America)

Company Profiled

• Astrazeneca Plc
• Amgen Inc.
• Bayer AG
• Boehringer Ingelheim GmBH
• Bristol-Myers Squibb Co.
• Daiichi Sankyo Co. Ltd.
• Eli Lilly and Co.
• F. Hoffmann-La Roche Ltd.
• Glaxosmithkline PLC
• Gilead Sciences, Inc.
• Johnson & Johnson
• Merck & Co., Inc.
• Novartis AG
• Nissan Chemical Corp.
• Otsuka Holdings Co., Ltd.
• Pfizer, Inc.
• Sanofi S.A.
• Siemens Healthineer
• Takeda Pharmaceuticals Co. Ltd.
• Tenax Therapeutics, Inc.

The key objectives of the Global Cardio-Protective Drugs Market study:

• To analyze the Global Cardio-Protective Drugs Market st by segments with historical data of 2017 and 2018 and forecast to 2025.
• To study the key factors influencing the growth of the market.
• Focuses on the key leaders to define and analyze the sales volume, value, share, competitive landscapes, SWOT analysis, and development plans.
• To analyze the Global Cardio-Protective Drugs Market stgrowth, global trends, future prospectus and contribution to the market.

About Orion Market Research

Orion Market Research (OMR) is an Indian research company known for its crisp and concise reports. The company is equipped with an experienced team and young brigade of analysts. The company provides quality syndicated research reports, customized research reports, company profiling, consulting and other research-based services.

Media Contact:
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +1 646-755-7667,+91 780-304-0404